Investor Relations


Please fill out our Feedback Form and let us know how you like our Investor website.



Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on breast health, diagnostics, GYN surgical, and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts.

Hologic employs approximately 5,500 employees worldwide. The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol "HOLX".


Wednesday, April 9, 2014
Hologic to Release Second Quarter Fiscal 2014 Operating Results on Wednesday, April 30, 2014
Read Release
Listen to Webcast


Friday, March 14, 2014
Hologic Enhances Executive Leadership Structure to Drive Global Growth and Improve Operational Execution
Read Release

Thursday, March 13, 2014
Hologic to Showcase Total 3D Mammography (Tomosynthesis) Solution at National Consortium of Breast Centers (NCoBC) Annual Conference
Read Release


Thursday, March 6, 2014
Hologic Announces Positive Results of February AMA CPT Editorial Panel Meeting
Read Release


Monday, March 3, 2014
Hologic's Total Breast Tomosynthesis Solution and Other Leading-edge Products to be Featured at the European Congress of Radiology in Vienna
Read Release


Wednesday, February 26, 2014
Hologic Announces Completion of Term Loan B Refinancing
Read Release

Monday, February 10, 2014
Three New Peer-reviewed Publications Further Validate the Benefits of Hologic 3D Mammography (Tomosynthesis) in Breast Cancer Screening
Read Release

Monday, February 3, 2014
Hologic Announces First Quarter Fiscal 2014 Operating Results
Read Release
View Presentation